These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6012203)

  • 1. [Peculiarities of the pathogenic action of the antidiabetic sulfanilamide oranyl (carbutamide) at different stages of embryogenesis (experimental study)].
    Bariliak IR
    Akush Ginekol (Mosk); 1966 Dec; 42(12):35-40. PubMed ID: 6012203
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of sodium hydrocarbonate on the teratogenic activity of oranyl (carbutamide)].
    Bariliak IR
    Farmakol Toksikol; 1967; 30(5):631-3. PubMed ID: 5598925
    [No Abstract]   [Full Text] [Related]  

  • 3. [The simultaneous effect of oranyl (carbutamide) and sodium salicylate on the embryonic development of rats].
    Bariliak IR; Chebotar' NA
    Biull Eksp Biol Med; 1967 Aug; 64(8):100-4. PubMed ID: 5622528
    [No Abstract]   [Full Text] [Related]  

  • 4. [Carbutamide and malformations in children].
    Caldera R
    Ann Pediatr (Paris); 1970; 17(6):432-5. PubMed ID: 5421326
    [No Abstract]   [Full Text] [Related]  

  • 5. [The teratogenic risk].
    Tuchmann-Duplessis H
    Arch Anat Histol Embryol; 1968; 51(5):719-25. PubMed ID: 4917890
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peroral antidiabetics during pregnancy].
    Horký Z
    Zentralbl Gynakol; 1965 Jul; 87(28):972-5. PubMed ID: 5891417
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral antidiabetics in pregnancy].
    Heisig N
    Med Klin; 1971 Mar; 66(12):445-9. PubMed ID: 5576129
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of the effects of oranyl and cyclamide on the embryogenesis in albino rats].
    Bariliak IR
    Farmakol Toksikol; 1965; 28(5):616-21. PubMed ID: 5896205
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gougerot-Blum disease due to hypersensitivity to carbutamide].
    Dobozy A; Hunyadi J; Husz S
    Z Hautkr; 1974 Dec; 49(23):1009-12. PubMed ID: 4450612
    [No Abstract]   [Full Text] [Related]  

  • 10. [An additional case of agranulocytosis caused by carbutamide therapy].
    Schneider H; Rodemerk R; Berdau W; Mesewinkel F
    Dtsch Gesundheitsw; 1972 Mar; 27(13):581-3. PubMed ID: 5040767
    [No Abstract]   [Full Text] [Related]  

  • 11. [Extreme blood sugar depression from combined carbutamide-buformin therapy].
    Lotz U
    Dtsch Gesundheitsw; 1969 Jul; 24(29):1381-2. PubMed ID: 5376206
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tolbutamide instead of carbutamide].
    Magyar I; Benedict J; Bruncsák A; Illyés T
    Orv Hetil; 1971 Jan; 112(3):171. PubMed ID: 5540535
    [No Abstract]   [Full Text] [Related]  

  • 13. [Apropos of a case of medullar aplasia after treatment with carbutamide].
    Bertoye A; Garin JP; Monier P; Bertrand JL; Vauzelle JL; Dechaume JP
    Lyon Med; 1966 Dec; 216(52):1549-64. PubMed ID: 5986665
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON THE EFFECT OF ANTIDIABETIC SULFANILAMIDE PREPARATIONS ON FAT-LIPOID METABOLISM IN DIABETES MELLITUS].
    TRUNCHENKOVA ES
    Klin Med (Mosk); 1963 Jul; 41():63-7. PubMed ID: 14071115
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peculiarities of the pathogenic effect of sarcolysine on embryogenesis in rats].
    Aleksandrov VA
    Dokl Akad Nauk SSSR; 1966 Nov; 171(3):746-9. PubMed ID: 4968846
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of repeated applications of carbutamide on the embryonic development of the rat (author's transl)].
    Kreutz R
    Anat Anz; 1979; 146(5):427-38. PubMed ID: 546272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features peculiar to the pathogenic effect of chloridin at different stages of embryogenesis development (Experimental research)].
    Dyban AP; Akimova IM
    Akush Ginekol (Mosk); 1965; 41(6):21-8. PubMed ID: 5896089
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypoglycemic accidents in the therapeutic use of antidiabetic sulfamides (S.A.D.)].
    Argemi B; Melchior G; Lam-My S; Simonin R
    Mars Med; 1969; 106(10):783-9. PubMed ID: 5391194
    [No Abstract]   [Full Text] [Related]  

  • 19. [Case of Lyell's syndrome caused by bucarban].
    Shamov IA
    Klin Med (Mosk); 1978 Mar; 56(3):135-6. PubMed ID: 651296
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypoglycemic coma of antidiabetic sulfamides].
    Canivet J; Mantel O
    Journ Annu Diabetol Hotel Dieu; 1967; 7():349-63. PubMed ID: 4862372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.